Last reviewed · How we verify
NCT04579835: TWEXIT
Twin A Breech External Cephalic Version Intervention Trial (TWEXIT)
trial testing External Cephalic Version in Breech Presentation in 45 participants. Currently enrolling.
28 September 2025
Quick facts
| Lead sponsor | Charite University, Berlin, Germany |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 45 |
| Start date | 28 September 2020 |
| Primary completion | 28 September 2025 |
| Estimated completion | 28 September 2026 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- External Cephalic Version
Conditions studied
- Breech Presentation — all drugs for Breech Presentation →
- Twin; Complicating Pregnancy — all drugs for Twin; Complicating Pregnancy →
Sponsor
Charite University, Berlin, Germany
Who can join
18 and older, female only, with Breech Presentation or Twin; Complicating Pregnancy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective study assessing the use of external cephalic version for the management of Twin A breech presentation in twin pregnancy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04579835
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breech Presentation
Currently open trials in the same condition.
- NCT06187948 — An Informative Video Before Planned External Cephalic Version · NA · recruiting
- NCT06816563 — Prediction of Version Outcomes for External Maneuvers of Breech Fetus by Assessment of Breech Progression Angle · recruiting
Other Charite University, Berlin, Germany trials
Trials by the same sponsor.
- NCT07486167 — Influence of Lung Volume Optimization Maneuver on Cardiac Output and Lung Compliance in Ventilated Children With Congeni · Phase 1, PHASE2 · not yet recruiting
- NCT07476729 — International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) · Phase 3 · not yet recruiting
- NCT07503054 — Ovarian Cancer Screening and AI · NA · not yet recruiting
- NCT07529197 — Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS · recruiting
- NCT07388693 — Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04579835 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Charite University, Berlin, Germany
- Last refreshed: 6 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04579835.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing